Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


  • Edwards Lifesciences Corp (NYSE:EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57.
  • Sales increased 10% to $1.34 billion (underlying 13%), beating the consensus of $1.31 billion.
  • Transcatheter aortic valve replacement sales grew to $881 million, up 11%. Globally, the company's average selling price and market position were stable. 
  • Related: FDA Approves Edwards Lifesciences' Resilia Valve For Mitral Replacement Surgery.
  • U.S. TAVR sales grew approximately 10%, and adoption was broad-based across hospitals. 
  • TAVR sales outside the U.S. grew about 20% Y/Y.
  • EW held cash and equivalents of $1.5 billion as of March 31, 2022.
  • Guidance: Edwards Lifesciences reaffirmed its FY22 projection of adjusted EPS of $2.50 - $2.65 (consensus of $2.55) and reiterated its top-line outlook of $5.5 billion - $6.0 billion (consensus $5.76 billion).
  • For Q2 FY22, Edwards Lifesciences expects revenue of $1.36 billion - $1.44 billion (consensus $1.46 billion) and adjusted EPS of $0.61 - $0.69 (consensus $0.65).
  • Analyst Reaction: SVB Leerink analyst Danielle Antalffy maintained an Outperform but lowered the price target from $145 to $138.
  • RBC Capital analyst Shagun Singh maintained an Outperform and lowered the price target from $142 to $135.
  • Raymond James analyst Jayson Bedford maintained an Outperform and reduced the price target from $126 to $124.
  • Price Action: EW shares traded 3.67% lower at $112.00 during pre-market trading on Wednesday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorEarningsNewsGuidanceHealth CarePrice TargetReiterationAnalyst RatingsMoversTrading IdeasGeneralBriefs